Essential medicines price capping resulted in saving of Rs 12500 crore, says Kovind Farhat Nasim2 Feb 2020 12:00 PM IST Addressing the joint sitting of both houses of Parliament, on the first day of the Budget session here, Kovind said capping of prices of more than...
DPCO has led to increase in prices by about 21pc for cheaper drugs: Survey Farhat Nasim1 Feb 2020 2:43 PM ISTThe Survey said its estimates also show that the DPCO, 2013 order increased prices by about 21 per cent for the cheaper formulations. However, in the...
Minister informs Parliament about steps taken to promote affordable generic drugs Medical Dialogues Bureau26 Nov 2019 4:30 PM ISTNew Delhi: The Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently informed the Parliament about the steps taken by the...
Definition of generic drugs discussed in Parliament Farhat Nasim7 July 2019 9:50 AM ISTHe said that the generic medicines are generally those which contain some amount of same active ingredients in same dosage form, and are intended to...
More than 10 percent of Drug samples from Government sources Not of Standard Quality Meghna A Singhania25 Jun 2019 3:43 PM ISTNew Delhi: Estimated 10.02% medicines of the sample of medicines from government sources tested by the government were found to be Not of Standard...
Minister notifies Parliament: Precautions to curb unsafe medical syringes in the market Farhat Nasim16 Dec 2018 10:05 AM ISTNew Delhi: Responding to a query raised in Rajya Sabha, Ministry of Health and Family Welfare informed the parliament about the precautions taken by...
China accounts for 66 percent of India's bulk drug imports in FY'17 Ruby Khatun Khatun20 Dec 2017 10:15 AM ISTNew Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament...
Pharma, medical devices should be under one ministry: Mansukh L Mandaviya Ruby Khatun Khatun10 Aug 2017 10:00 AM ISTNew Delhi: The Department of Pharmaceuticals (DoP) feels that subjects and regulatory bodies related to pharmaceuticals and medical devices should...
